← FDA DRUG APPROVALS

FDA ANDA · ANDA211240

CLOBETASOL PROPIONATE

Sponsor: QUAGEN

APPLICATION
ANDA211240
TYPE
ANDA
ORIGINAL APPROVAL
2022-02-17
LATEST ACTION
2022-02-17
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · SOLUTION · TOPICAL

Approval history

2022-02-17UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →